SCHEMBL10129501

SCHEMBL10129501

CC(C)c1nc(N(C)C)nc(-c2ccc(F)cc2)c1Br

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HMGCR P04035 2/20 0.38
HDAC1 Q13547 1/20 0.38
HDAC2 Q92769 1/20 0.38
HDAC6 Q9UBN7 1/20 0.38
ALDH1A1 P00352 4/20 0.38
CYP3A4 P08684 2/20 0.38
PDE6D O43924 1/20 0.38
NR1I2 O75469 1/20 0.38
PDE4D Q08499 1/20 0.38
CASP1 P29466 3/20 0.37
CASP7 P55210 3/20 0.37
HSD17B10 Q99714 3/20 0.37
CYP1A2 P05177 2/20 0.37
GLA P06280 1/20 0.37
ABCC3 O15438 1/20 0.37
ABCC4 O15439 1/20 0.37
USP2 O75604 2/20 0.36
HIF1A Q16665 2/20 0.36
MEN1 O00255 1/20 0.36
CYP2D6 P10635 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2341001 0.84 HMGCR (0.54) HMGCRHDAC1HDAC2HDAC6ALDH1A1
SCHEMBL10129544 0.84 KDM5B (0.41) HMGCRHDAC1HDAC2HDAC6ALDH1A1
SCHEMBL10129494 0.84 GCGR (0.46) HMGCRHDAC1HDAC2HDAC6ALDH1A1
SCHEMBL10129495 0.83 GCGR (0.43) HMGCRALDH1A1CYP3A4PDE6DNR1I2
SCHEMBL10129522 0.81 GCGR (0.57) HMGCRALDH1A1CYP3A4PDE6DNR1I2
SCHEMBL20146246 0.80 GCGR (0.43) HMGCRALDH1A1CYP3A4PDE6DNR1I2
SCHEMBL10129258 0.79 HMGCR (0.47) HMGCRHDAC1HDAC2HDAC6ALDH1A1
SCHEMBL2343909 0.79 ADORA2A (0.45) GCGRHTR2AHTR2CHTR2BSCN9A
SCHEMBL2342322 0.79 GCGR (0.40) GCGRHTR2AHTR2CHTR2B
SCHEMBL2340496 0.79 GCGR (0.43) GCGRHTR2AHTR2CHTR2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012013325-A1 PROCESS FOR THE PREPARATION OF KEY INTERMEDIATES FOR THE SYNTHESIS OF STATINS OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF LEK PHARMACEUTICALS D.D. (SI) 2012-02-02 WO disclosed